価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-C9orf72, Mouse-Mono(GT779)
データシート
GTX632041 GNTジーンテックス
GeneTex International Corporation
100 μl ¥85,000 1個 追加

在庫・価格 : 2025年04月29日 23時55分 現在

Anti-C9orf72, Mouse-Mono(GT779)

  • 商品コード:GTX632041
  • メーカー:GNT
  • 包装:100μl
  • 価格: ¥85,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Laflamme C et al. Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72. Elife 2019 10;8
Laflamme C et al
2019/01/01
PubMed
2 Carl Laflamme et al., Carl Laflamme, bioRxiv, 2018

PubMed
3 Liu Y et al. Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models. Nat Commun 2021 02;12(1):847
Liu Y et al
2021/01/01
PubMed
4 Limone F et al. Myeloid and lymphoid expression of <i>C9orf72</i> regulates IL-17A signaling in mice. Sci Transl Med 2024 Jan;16(732):eadg7895
Limone F et al
2024/01/01
PubMed
5 Salomonsson SE et al. Validated assays for the quantification of C9orf72 human pathology. Sci Rep 2024 Jan;14(1):828
Salomonsson SE et al
2024/01/01
PubMed
6 He L et al. C9orf72 functions in the nucleus to regulate DNA damage repair. Cell Death Differ 2023 Mar;30(3):716-730
He L et al
2023/01/01
PubMed
7 Chen ZS et al. Mutant GGGGCC RNA prevents YY1 from binding to Fuzzy promoter which stimulates Wnt/&#x3B2;-catenin pathway in C9ALS/FTD. Nat Commun 2023 Dec;14(1):8420
Chen ZS et al
2023/01/01
PubMed
8 Seidel M et al. Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD <i>in vitro</i> models. Curr Res Neurobiol 2023;5:100105
Seidel M et al
2023/01/01
PubMed
9 J端lg J et al. C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. EMBO Rep 2023 Aug;24(8):e55895
J端lg J et al
2023/01/01
PubMed
10 Mira Seidel et al., Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD in vitro models., Curr Opin Neurobiol., 2023., 5., 2023., 100105

PubMed
11 Liu Y et al. Hyperactivity of Purkinje cell and motor deficits in C9orf72 knockout mice. Mol Cell Neurosci 2022 Jul;121:103756
Liu Y et al
2022/01/01
PubMed
12 Ghaffari LT et al. Differential response of C9orf72 transcripts following neuronal depolarization. iScience 2023 Jun;26(6):106959
Ghaffari LT et al
2023/01/01
PubMed
13 Pang W et al. C9ORF72 suppresses JAK-STAT mediated inflammation. iScience 2023 May;26(5):106579
Pang W et al
2023/01/01
PubMed
14 Bauer CS et al. An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD. Acta Neuropathol 2022 Sep;144(3):437-464
Bauer CS et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Laflamme C et al. Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72. Elife 2019 10;8
    Laflamme C et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Carl Laflamme et al., Carl Laflamme, bioRxiv, 2018

  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Liu Y et al. Variant-selective stereopure oligonucleotides protect against pathologies associated with C9orf72-repeat expansion in preclinical models. Nat Commun 2021 02;12(1):847
    Liu Y et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Limone F et al. Myeloid and lymphoid expression of <i>C9orf72</i> regulates IL-17A signaling in mice. Sci Transl Med 2024 Jan;16(732):eadg7895
    Limone F et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Salomonsson SE et al. Validated assays for the quantification of C9orf72 human pathology. Sci Rep 2024 Jan;14(1):828
    Salomonsson SE et al
    2024/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    He L et al. C9orf72 functions in the nucleus to regulate DNA damage repair. Cell Death Differ 2023 Mar;30(3):716-730
    He L et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Chen ZS et al. Mutant GGGGCC RNA prevents YY1 from binding to Fuzzy promoter which stimulates Wnt/&#x3B2;-catenin pathway in C9ALS/FTD. Nat Commun 2023 Dec;14(1):8420
    Chen ZS et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Seidel M et al. Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD <i>in vitro</i> models. Curr Res Neurobiol 2023;5:100105
    Seidel M et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    J端lg J et al. C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. EMBO Rep 2023 Aug;24(8):e55895
    J端lg J et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Mira Seidel et al., Propranolol reduces the accumulation of cytotoxic aggregates in C9orf72-ALS/FTD in vitro models., Curr Opin Neurobiol., 2023., 5., 2023., 100105

  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Liu Y et al. Hyperactivity of Purkinje cell and motor deficits in C9orf72 knockout mice. Mol Cell Neurosci 2022 Jul;121:103756
    Liu Y et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Ghaffari LT et al. Differential response of C9orf72 transcripts following neuronal depolarization. iScience 2023 Jun;26(6):106959
    Ghaffari LT et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Pang W et al. C9ORF72 suppresses JAK-STAT mediated inflammation. iScience 2023 May;26(5):106579
    Pang W et al
    2023/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Bauer CS et al. An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD. Acta Neuropathol 2022 Sep;144(3):437-464
    Bauer CS et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed